The global liver cancer screening market size reached a value of more than USD 11.99 Billion in 2024. The market value is expected to grow at a CAGR of 7.20% in the forecast period of 2025-2034, reaching a value of USD 24.03 Billion by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Billion
2025-2034
Liver Cancer Screening Market Outlook
*this image is indicative*
Rising Health Awareness Among People
The number of programs is multiplying to raise awareness for early diagnosis of any disorder. This will increase the number of people visiting medical centres, which will propel the market growth.
Untapped Market in Developing Regions
Developing countries in Asia and Africa lack the technology and experts to manufacture devices themselves. This creates a lucrative opportunity for major players to expand their market in those regions.
The High Cost of Technology
The high cost of advanced liver cancer diagnostic devices is a major restraining factor for the market growth in the developing regions.
Lacking Reimbursement Plans
The lack of proper policies for reimbursement and insurance of diagnostic plans and treatments can hinder the market growth.
Cancer is a term used for multiple tumours that can develop in any of the body parts and in the later stages they can spread uncontrollably to the other parts of the body. Among the different types of liver cancer, the most common type of liver cancer is hepatocellular, which starts in the main part of the liver cell called hepatocyte.
Based on type, the market can be segmented into hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma, among others. Based on the screening, it can be bifurcated into laboratory tests, imaging tests, endoscopy, and biopsy, among others. Based on end-use, the market segments include hospitals and diagnostic laboratories, pharmaceutical and CRO laboratories, and academic and research institutes, among others.
The regional markets for the liver cancer screening market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
The extensive E.M.R. report provides an in-depth evaluation of the market based on Porter's five forces model and a SWOT analysis
In the liver cancer screening market, the segments include hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma, among others. Among these, hepatocellular carcinoma is the most common type of liver disease and its usually found in people with chronic liver disease or damaged liver due to hepatitis B or C.
Cholangiocarcinoma, also known as Bile Duct Cancer, is a type of cancer disease that develops in the slender tubes in the liver that carries digestive bile fluids. This segment is expected to develop as the ageing population in the world increases.
The market, based on screenings, is segmented into laboratory tests, imaging tests, endoscopy, and biopsy, among others. Among these screenings, imaging tests hold a major share of the market. There are different types of imaging tests including CT (computed tomography) and MRI (magnetic resonance imaging), which are the most common types of imaging.
An imaging test is used by specialists to get pictures of the inside of a body and analyse the condition of the part. These tests are often used for early diagnosis of cancer.
Endoscopy is a non-surgical method of a visual examination of a person’s digestive tract. In this procedure a long, thin tube is directly inserted, with a camera on the tube’s end, to examine the organs and tissue.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd is more commonly known as Roche. It is a multinational healthcare company based in Switzerland and founded in 1896. Their primary focus lies around two sectors- pharmaceuticals and diagnostics. They have increased their focus on early detection of diseases and accurate diagnosis to develop personalised healthcare.
Abbott Laboratories is a major player working in the field of healthcare providing solutions and diagnostics, medical devices, and medicines. This American multinational company is headquartered in Illinois, United States.
Siemens Healthineers AG is a German multinational company with a focus on medical devices, founded in 1847. They provide services for in-vitro and in-vivo diagnostics and image-guided therapy. They conduct research and development to develop new and innovative cancer care by combining the latest technologies, like artificial intelligence (AI) and big data.
Koninklijke Philips N.V. is a technology company engaged in multiple fields like healthcare, household electronics, and lighting to improve people’s lifestyle. They provide a wide variety of equipment for diagnosis, including radiography, ultrasound, imaging, and monitoring, among other services.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Epigenomics AG, Thermo Fisher Scientific Corporation, FUJIFILM Holdings America Corporation, among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2024, the market attained a value of USD 11.99 Billion, driven by the rising number of cases.
The market for lung cancer screening is expected to grow at a CAGR of 7.20% during the period 2025-2034.
The market is expected to reach a value of USD 24.03 Billion by 2034.
The liver cancer screening market is driven by the rising cases of chronic liver disorders and increasing efforts in research and development.
The rising early health diagnosis awareness and increasing government efforts to develop healthcare services and promotion of better services to increase awareness are key trends in the market.
The regional markets for the global lung therapeutics market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
The types of cancer in the market for liver cancer screening include hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma, among others.
The market segments for liver cancer screening, based on screening, include laboratory tests, imaging tests, endoscopy, and biopsy, among others.
Based on end-use, the market segments include hospitals and diagnostic laboratories, pharmaceutical and CRO laboratories, academic and research institutes, among others.
Alpha-fetoprotein (AFP) is the most widely used method for detecting liver cancer.
A CT scan can give detailed images of your internal organs and help in acquiring different information like the size, shape, and location of the tumour.
The key players in the market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., Becton, Dickinson and Company, Epigenomics AG, Thermo Fisher Scientific Corporation, and FUJIFILM Holdings America Corporation, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Screening |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share